Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts

Sponsor
University of Belgrade (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06096220
Collaborator
(none)
50
1
2
60
0.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare surgical treatment outcomes of odontogenic keratocysts (OKC) treated with enucleation and local application of Carnoy's solution or 5% 5-fluorouracil. The main questions it aims to answer are:

  1. What is the recurrence rate of OKC treated with enucleation and local application of 5% 5-fluorouracil cream in the period of three and five years after the treatment

  2. What is the recurrence rate of OKC treated with enucleation and local application of Carnoy's solution in the period of three and five years after the treatment

  3. Is there a difference in the recurrence rate between these two groups

  4. What is the frequency of sensitivity disorders in the innervation zone of inferior alveolar and infraorbital nerves in both groups

Participants will be assigned to one of two groups after Histopathological verification (HP verification).They will be treated with enucleation and local application of Carnoy's solution or 5% 5-fluorouracil depending on group. After surgical treatment they will be monitored in accordance to standard treatment protocols for patients with OKC.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Enucleation
  • Diagnostic Test: incisional biopsy
  • Drug: Application of 5-fluorouracil
  • Drug: Application of Carnoy solution
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts - Randomized, Controlled Clinical Study
Actual Study Start Date :
Jun 10, 2023
Anticipated Primary Completion Date :
Jun 10, 2024
Anticipated Study Completion Date :
Jun 10, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

Enucleation of OKC followed by local application of 5% 5-fluorouracil cream. Drug will be applied on the gauze left in the enucleation defect for 24 hours, after which the gauze will be removed.

Procedure: Enucleation
Enucleation is complete removal of the cyst from the bony defect of the jaw affected by the lesion. Osteotomy is performed to allow access to the cyst, cystic wall is detached from the bone and removed completely.

Diagnostic Test: incisional biopsy
Lesions clinically abd radiographically consistent with OKC will be submitted for histological examination to confirm the diagnosis of OKC

Drug: Application of 5-fluorouracil
5% 5-fluorouracil cream will be applied immediately after the enucleation to the cystic cavity for 24 hours

Active Comparator: Control group

Enucleation of OKC followed by local application Carnoy solution. Carnoy solution will be applied into the cystic cavity for 5 minutes and bone defect will be treated by Carnoy solution for 3 minutes immediately after the enucleation.

Procedure: Enucleation
Enucleation is complete removal of the cyst from the bony defect of the jaw affected by the lesion. Osteotomy is performed to allow access to the cyst, cystic wall is detached from the bone and removed completely.

Diagnostic Test: incisional biopsy
Lesions clinically abd radiographically consistent with OKC will be submitted for histological examination to confirm the diagnosis of OKC

Drug: Application of Carnoy solution
Carnoy solution will be applied during the enucleation as described previously

Outcome Measures

Primary Outcome Measures

  1. Recurrence rate [5 years]

    Number of participants with histologically verified OKC in site of previously treated OKC

Secondary Outcome Measures

  1. Sensitivity disorders [Immediately after the surgery up to one month]

    dysesthesia and hypoesthesia in the surgical site

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Histologically verified OKC of the upper or lower jaw;

  • Indicated surgical treatment of OKC

Exclusion Criteria:
  • Hypersensitivity to 5-fluorouracil and Carnoy's solution;

  • Pathological fracture of the jaw in OKC region.

  • Nevoid basal cell carcinoma

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of Dental Medicine Belgrade Serbia 11000

Sponsors and Collaborators

  • University of Belgrade

Investigators

  • Study Chair: Miroslav Andric, University of Belgrade, School of Dental Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Miroslav Andric, Professor of Oral Surgery and Implantology, University of Belgrade
ClinicalTrials.gov Identifier:
NCT06096220
Other Study ID Numbers:
  • 36/17-2023
First Posted:
Oct 23, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 23, 2023